Dose-regimen dependent caffeic acid prevention of acute liver damage.
Pérez-Alvarez
V
V
Departamento de Farmacología y Toxicología, CINVESTAV IPN, México, D.F., México.
Bobadilla
R A
RA
Alias
A
A
Rico
M
M
Muriel
P
P
D000410:Alanine Transaminase / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001663:Bilirubin / Q000378:metabolism; D002109:Caffeic Acids / Q000627:therapeutic use*; D002252:Carbon Tetrachloride Poisoning / Q000201:enzymology / Q000378:metabolism / Q000517:prevention & control*; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000378:metabolism / Q000517:prevention & control*; D004305:Dose-Response Relationship, Drug; D006160:Guanosine Triphosphate / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D000975:Antioxidants; D002109:Caffeic Acids; D006160:Guanosine Triphosphate; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin; C040048:caffeic acid